Synergy between Colistin and the Signal Peptidase Inhibitor MD3 Is Dependent on the Mechanism of Colistin Resistance in Acinetobacter baumannii.

about

Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options Insight into : pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities

P2860

Q30235064-7FDAA6FC-C73E-4524-BF42-A5340CD3F3E5 Q57168270-F480F72B-C96A-4491-823F-2E132EC191B8

P2860

Synergy between Colistin and the Signal Peptidase Inhibitor MD3 Is Dependent on the Mechanism of Colistin Resistance in Acinetobacter baumannii.

Item

http://www.wikidata.org/entity/Q40690118

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Synergy between Colistin and t ...... ce in Acinetobacter baumannii.

@en

type

Item

label

Synergy between Colistin and t ...... ce in Acinetobacter baumannii.

@en

prefLabel

Synergy between Colistin and t ...... ce in Acinetobacter baumannii.

@en

P1476

Synergy between Colistin and t ...... ce in Acinetobacter baumannii.

@en

P2093

Alejandro Beceiro

http://www.w3.org/2001/XMLSchema#string

David W Wareham

http://www.w3.org/2001/XMLSchema#string

Joshua Odingo

http://www.w3.org/2001/XMLSchema#string

Margarita Poza

http://www.w3.org/2001/XMLSchema#string

Richard D Waite

http://www.w3.org/2001/XMLSchema#string

Tanya Parish

http://www.w3.org/2001/XMLSchema#string

P2860

Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study

Signal peptidases

Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system.

OXA-24, a novel class D beta-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain.

Drugs of last resort? The use of polymyxins and tigecycline at US Veterans Affairs medical centers, 2005-2010.

Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production.

Different surface charge of colistin-susceptible and -resistant Acinetobacter baumannii cells measured with zeta potential as a function of growth phase and colistin treatment

Acinetobacter baumannii: emergence of a successful pathogen

In Vivo Selection of Pan-Drug Resistant Acinetobacter baumannii during Antibiotic Treatment

Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system.

P304

4375-4379

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00510-16

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Juan C Vázquez-Ucha

German Bou

M Martínez-Guitián

P577

2016-05-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27139471

http://www.w3.org/2001/XMLSchema#string

P921

Acinetobacter baumannii

P932

4914650

http://www.w3.org/2001/XMLSchema#string

Synergy between Colistin and the Signal Peptidase Inhibitor MD3 Is Dependent on the Mechanism of Colistin Resistance in Acinetobacter baumannii.

about

P2860

P2860

Synergy between Colistin and the Signal Peptidase Inhibitor MD3 Is Dependent on the Mechanism of Colistin Resistance in Acinetobacter baumannii.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932